Ambry Genetics drives innovation in diagnostics ... including clinical exome and hereditary cancer panels. We strive to develop the most accurate, highest quality tests possible.

Early cancer detection through advanced imaging remains a cornerstone of breast cancer care. Identifying high-risk patients is crucial for implementing personalized screening protocols that can ...

Marcy Richardson from Ambry Genetics ... their options for cancer treatment are moot. Now, with functional data readily available, , we are more likely to classify it the first time we see it, which ...

Elliott and colleagues simulated a false-positive rate of zero when comparing the results of 20,000 hereditary cancer, NGS panels—including 47 disease-NGS alone, the researchers “missed [the] ...

From 2016 to 2021, Aaron led Ambry Genetics as CEO and transformed ... including the first CLIA/CAP exome test, hereditary cancer panels, and paired RNA and DNA germline tests.

Sydney: Medical researchers have developed advanced computational tools that significantly improve the accuracy of genetic testing for inherited cancer risk ... and U.S.-based Ambry Genetics ...